Bruker Corp (BRKR)
80.59
-1.61
(-1.96%)
USD |
NASDAQ |
Apr 25, 16:00
80.54
-0.05
(-0.06%)
Pre-Market: 20:00
Bruker SG&A Expense (Quarterly): 211.80M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 211.80M |
September 30, 2023 | 177.60M |
June 30, 2023 | 177.90M |
March 31, 2023 | 162.80M |
December 31, 2022 | 167.10M |
September 30, 2022 | 145.10M |
June 30, 2022 | 152.60M |
March 31, 2022 | 146.00M |
December 31, 2021 | 156.60M |
September 30, 2021 | 141.30M |
June 30, 2021 | 134.80M |
March 31, 2021 | 131.90M |
December 31, 2020 | 134.80M |
September 30, 2020 | 114.90M |
June 30, 2020 | 103.50M |
March 31, 2020 | 124.60M |
December 31, 2019 | 133.10M |
September 30, 2019 | 125.90M |
June 30, 2019 | 125.10M |
March 31, 2019 | 120.10M |
December 31, 2018 | 123.50M |
September 30, 2018 | 107.40M |
June 30, 2018 | 111.90M |
March 31, 2018 | 110.30M |
December 31, 2017 | 113.70M |
Date | Value |
---|---|
September 30, 2017 | 104.10M |
June 30, 2017 | 104.30M |
March 31, 2017 | 98.10M |
December 31, 2016 | 104.00M |
September 30, 2016 | 96.80M |
June 30, 2016 | 100.90M |
March 31, 2016 | 92.70M |
December 31, 2015 | 103.00M |
September 30, 2015 | 96.50M |
June 30, 2015 | 98.50M |
March 31, 2015 | 104.80M |
December 31, 2014 | 118.60M |
September 30, 2014 | 108.30M |
June 30, 2014 | 115.60M |
March 31, 2014 | 111.70M |
December 31, 2013 | 119.10M |
September 30, 2013 | 106.40M |
June 30, 2013 | 109.50M |
March 31, 2013 | 109.00M |
December 31, 2012 | 115.80M |
September 30, 2012 | 105.90M |
June 30, 2012 | 112.80M |
March 31, 2012 | 106.90M |
December 31, 2011 | 121.30M |
September 30, 2011 | 102.10M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
103.50M
Minimum
Jun 2020
211.80M
Maximum
Dec 2023
145.65M
Average
141.30M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Azenta Inc | 78.58M |
Harvard Bioscience Inc | 11.51M |
Bionano Genomics Inc | 15.69M |
Akoya Biosciences Inc | 18.90M |
Singular Genomics Systems Inc | 13.13M |